Dr. Hollmann is a pathologist with clinical training in dermatopathology who focuses on cutaneous tumor immunology. As a Melanoma Research Alliance young investigator and a member of both the melanoma and lung immunotherapy Stand Up to Cancer science teams, he has recently contributed to studies of the correlation between tumor neoantigens and response to immunotherapeutics. He has been involved in numerous basic and clinical investigational studies of melanoma biology and immunology. He also serves as a study pathologist for checkpoint inhibitor trials at MSK.
Education & Training
- University of Texas Medical School, Houston, MD, PhD